Although survival extension in xenograft models supports target engagement [4], PHGDH inhibition in MYCN-amplified neuroblastoma models primarily induces cytostatic effects rather than cytotoxicity, and tumors rapidly develop resistance through metabolic rewiring [4]. Here, PHGDH is linked to neuroblastoma.